Dianthus Therapeutics, Inc. (DNTH)

NASDAQ: DNTH · Real-Time Price · USD

16.52

-1.34 (-7.50%)

Apr 3, 2025, 3:01 PM EDT - Market open

Dianthus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 3, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	531	645	154	-	-
Market Cap Growth	318.69%	318.69%	-	-	-
Enterprise Value	172	364	-35	-	-
Last Close Price	17.86	21.80	10.40	-	-
PS Ratio	95.43	103.48	54.53	-	-
PB Ratio	1.58	1.83	0.91	-	-
P/TBV Ratio	1.83	1.83	0.91	-	-
EV/Sales Ratio	27.56	58.45	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	-
Asset Turnover	0.02	0.02	0.02	0.14	-
Quick Ratio	14.96	14.96	18.09	9.86	1.70
Current Ratio	15.22	15.22	18.43	9.97	1.75
Return on Equity (ROE)	-32.60%	-32.60%	-35.92%	-73.25%	-
Return on Assets (ROA)	-23.01%	-23.01%	-22.94%	-40.12%	-
Return on Capital (ROIC)	-24.33%	-24.33%	-24.69%	-47.27%	-
Earnings Yield	-16.11%	-13.17%	-28.26%	-	-
FCF Yield	-14.85%	-12.13%	-23.99%	-	-
Buyback Yield / Dilution	-546.44%	-546.44%	-489.48%	78.17%	-

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q